AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CHICAGO -- Jim Collins, editor of the OTC Insight newsletter, says November is a good time for acquiring stocks. Read about Kendle, Intl. (NASDAQ:KNDL), Hansen Natural (NASDAQ:HANS), Netflix (NASDAQ:NFLX), Astec Industries (NASDAQ:ASTE), and NICE Systems (NASDAQ:NICE). Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84
Highlights from the November 1 Featured Expert column by Jim Collins include:
Analysts' Review
Kendle, Intl. (NASDAQ:KNDL) is a contract research organization that provides clinical research services worldwide. Services constitute clinical trial management, clinical data management, statistical analysis, medical writing, regulatory consultation, organizational meeting management and publication services on a contract basis to the pharmaceutical and biotechnology industries.
Financials For the quarter ended September 30, 2005, Kendle reported earnings of $.24 per share, $.20 more than the $.04 per share reported last year. Revenues increased 20% to $52 million compared with $43 million in the same quarter last year. The revenue breakdown by geography was as follows: 57% North America, 40% Europe, and 3% Asia-Pacific.
Other names from the Buy List include:
Hansen Natural (NASDAQ:HANS) is a holding company and carries on no operating business except through its direct wholly-owned subsidiaries, Hansen Beverage Company and Hard e Beverage Company. Hansen is engaged in the business of marketing, selling and distributing so-called alternative beverage category.